The White House has been playing offense on policy, making several announcements before, during and after last week’s State of the Union address. Unless the initiatives are heavy on executive branch action, I’m not especially optimistic about their success.
But this announcement from the White House has me in a slightly more positive frame of mind. It would nearly double Federal funding for fighting antibiotic resistance in the fiscal year 2016 budget. It’s follow-through on the 2014 Executive Order related to antibiotic resistance and other government actions since the President made this an area of focus back in 2013.
Most of the requested increase would go to the Department of Health and Human Services (which covers the National Institutes of Health, the Centers for Disease Control and the Food and Drug Administration), but funding on antibiotic resistance would also grow at the Departments of Agriculture, Veterans Affairs and Defense. The fact sheet outlines a long list of programs that this money will help support, as well as some aggressive potential outcomes
- Reduce the incidence of carbapenem-resistant Enterobacteriaceae (CRE) infections by 60 percent.
- Reduce the incidence of Clostridium difficile infection (CDI) and methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections by 50 percent.
- Reduce the incidence of multidrug-resistant Pseudomonas infections acquired during hospitalization by 35 percent.
- Spur at least a 25 percent reduction in the rate of multi-drug resistant Salmonella infections and pediatric and geriatric antibiotic-resistant invasive pneumococcal disease.